Hiroyuki Konishi

Professor

Aichi Medical University

Japan

Research Interests

Explore related searches

Professors in Japan Professors in Cancer Biology Cancer Biology professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Hiroyuki Konishi is a Professor at Aichi Medical University in Japan. His research focuses on genome editing efficiency, targeted therapies for various types of leukemia, and the molecular mechanisms underlying malignant mesothelioma. Recent publications include studies on flow cytometry techniques and novel therapeutic targets in cancer treatment.

Articles (13)

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

Aichi Medical University

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Hiroyuki Konishi

Research Interests

Explore related searches

Contact this professor

About

Articles (13)

CAMK2D: a novel molecular target for BAP1-deficient malignant mesothelioma

PDZ‐binding kinase inhibitor OTS514 suppresses the proliferation of oral squamous carcinoma cells

Flow cytometry-based quantification of genome editing efficiency in human cell lines using the L1CAM gene.

BCL6 inhibition ameliorates ruxolitinib resistance in CRLF2-rearranged acute lymphoblastic leukemia.

Correction of a CD55 mutation to quantify the efficiency of targeted knock-in via flow cytometry.

Plumbagin-induced anticancer effects are associated with mitochondrial-encoded respiratory gene downregulation in oral squamous cell carcinoma

Experimental strategies to achieve efficient targeted knock-in via tandem paired nicking.

CD52 is a novel target for the treatment of FLT3-ITD-mutated myeloid leukemia

Flow cytometry-based quantification of targeted knock-in events in human cell lines using a GPI-anchor biosynthesis gene PIGP

Biallelic loss of FAM46C triggers tumor growth with concomitant activation of Akt signaling in multiple myeloma cells

Discovery of novel molecular characteristics and cellular biological properties in ameloblastoma

Tandem Paired Nicking Promotes Precise Genome Editing with Scarce Interference by p53

Identification of CD24 as a potential diagnostic and therapeutic target for malignant pleural mesothelioma.

Collaborators (6)

Sivasundaram Karnan

Shinobu Tsuzuki

Takuji Ito

Akinobu Ota

Kaori Uchino

Toshinori Hyodo

Make your next move.